MD Anderson Cancer Center named Artemio Mier associate vice president of revenue cycle, patient business services.

Michal Mego, winner of 2024, ESET Science Award public prize, founded top research lab when he returned to Slovakia.

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...

Nate Anderson: Hindenburg Research, a forensic financial research firm led by founder Nate Anderson, has been disbanded after completing its pipeline of investigative cases. Known for targeting ...

Founder of Hindenburg Research, Nathan Anderson has announced his decision to disband the US-based investment research firm. Hindenburg’s reports had caused investors to sell stocks and led to ...

Nathan Anderson is a prominent figure in the world of finance, best known as the founder of Hindenburg Research, a firm dedicated to uncovering corporate fraud and promoting transparency in the ...

Back for their fifth collaboration, Uniqlo x JW Anderson is here to remind us of the timeless allure that surrounds preppy fashion. As seen on last season's runways, the classic trend shows no ...

By Roni Caryn Rabin More Americans are surviving cancer, but the disease is striking young and middle-aged adults and women more frequently, the American Cancer Society reported on Thursday.

Nate Anderson, who started Hindenburg in 2017, cited the toll of the “rather intense, and at times, all-encompassing” nature of the work as the reason for his decision, in a note published on ...

While the announcement is good news for the Princess of Wales, cancer experts describe the challenges of a life shadowed by an earlier diagnosis. By Gina Kolata Gina Kolata has reported on ...

I don’t know if it’s a cultural thing, but as life limiting illnesses go, cancer seems to be unique. It engenders fear into many, some people not even able to call it by name, preferring ...

Andrea Schietinger of Memorial Sloan Kettering Cancer Center, Weill Cornell Graduate School of Medical Sciences, and Parker Institute for Cancer Immunotherapy; and Mark Sundrud of Dartmouth College.